These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7583915)

  • 41. Cross-neutralizing antibodies to HIV-1ANT70 and HIV-1IIIB in sera of African and Belgian HIV-1-infected individuals.
    Nkengasong JN; Peeters M; Ndumbe P; Janssens W; Willems B; Fransen K; Ngolle M; Piot P; van der Groen G
    AIDS; 1994 Aug; 8(8):1089-96. PubMed ID: 7986404
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HIV-1-infected patients with envelope-specific lymphoproliferation or long-term nonprogression lack antibodies suppressing glycoprotein 120 antigen presentation.
    Chien PC; Chen D; Chen PD; Tuen M; Cohen S; Migueles SA; Connors M; Rosenberg E; Malhotra U; Gonzalez C; Hioe CE
    J Infect Dis; 2004 Mar; 189(5):852-61. PubMed ID: 14976603
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endogenous basic fibroblast growth factor is essential for cyclin E-CDK2 activity in multiple external cytokine-induced proliferation of AIDS-associated Kaposi's sarcoma cells: dual control of AIDS-associated Kaposi's sarcoma cell growth and cyclin E-CDK2 activity by endogenous and external signals.
    Murakami-Mori K; Mori S; Nakamura S
    J Immunol; 1998 Aug; 161(4):1694-704. PubMed ID: 9712033
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of efficacy of pooled sera in a human immunodeficiency virus antibody prevalence in population surveys.
    Pătraşcu IV
    Rev Roum Virol; 1990; 41(1):45-51. PubMed ID: 2223657
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Decreased accessory cell function by human monocytic cells after infection with HIV.
    Petit AJ; Tersmette M; Terpstra FG; de Goede RE; van Lier RA; Miedema F
    J Immunol; 1988 Mar; 140(5):1485-9. PubMed ID: 2964477
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibodies to the HIV-1 V3 loop in serum from infected persons contribute a major proportion of immune effector functions including complement activation, antibody binding, and neutralization.
    Spear GT; Takefman DM; Sharpe S; Ghassemi M; Zolla-Pazner S
    Virology; 1994 Nov; 204(2):609-15. PubMed ID: 7941328
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HIV-2 infection in Thailand.
    Chanbancherd P; Limpairojn N; Benenson M; Jugsudee A; Julananto P; Tienamporn P; Luecha W; Tasaniyananda C
    Asian Pac J Allergy Immunol; 2000 Dec; 18(4):245-8. PubMed ID: 11316046
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HTLV-1 seroprevalence in AIDS patients and in HIV-1 seropositive and seronegative subjects at risk for AIDS in northern Italy.
    Manca N; Caruso A; Bonfanti C; Savoldi E; Li Vigni R; Pirali F; Sapelli PL; Turano A
    Eur J Epidemiol; 1989 Mar; 5(1):37-41. PubMed ID: 2707393
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vascular endothelial growth factor (VEGF165) plasma level increase with immunodepression in AIDS patients with Kaposi's sarcoma.
    Mercié P; Devianne I; Viallard JF; Faure I; Pellegrin I; Leng B; Dupon M; Barbeau P; Fleury H; Pellegrin JL
    Microvasc Res; 1999 Mar; 57(2):208-10. PubMed ID: 10049669
    [No Abstract]   [Full Text] [Related]  

  • 50. Low antigenicity of HIV-1 rev: rev-specific antibody response of limited value as correlate of rev gene expression and disease progression.
    Reiss P; De Ronde A; Lange JM; De Wolf F; Dekker J; Danner SA; Debouck C; Goudsmit J
    AIDS Res Hum Retroviruses; 1989 Dec; 5(6):621-8. PubMed ID: 2692659
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HIV-1MN recombinant gp120 vaccine serum, which fails to neutralize primary isolates of HIV-1, does not antagonize neutralization by antibodies from infected individuals.
    Wrin T; Nunberg JH
    AIDS; 1994 Nov; 8(11):1622-3. PubMed ID: 7848602
    [No Abstract]   [Full Text] [Related]  

  • 52. Presence of antibodies to a putatively immunosuppressive part of human immunodeficiency virus (HIV) envelope glycoprotein gp41 is strongly associated with health among HIV-positive subjects.
    Klasse PJ; Pipkorn R; Blomberg J
    Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5225-9. PubMed ID: 2455899
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mononuclear and polymorphonuclear leucocyte dysfunction in male homosexuals with the acquired immunodeficiency syndrome (AIDS).
    Ras GJ; Eftychis HA; Anderson R; van der Walt I
    S Afr Med J; 1984 Nov; 66(21):806-9. PubMed ID: 6505884
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Abnormal amino-acid concentrations in the blood of patients with acquired immunodeficiency syndrome (AIDS) may contribute to the immunological defect.
    Dröge W; Eck HP; Näher H; Pekar U; Daniel V
    Biol Chem Hoppe Seyler; 1988 Mar; 369(3):143-8. PubMed ID: 2897198
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Augmented serum neutralizing activity against primary human immunodeficiency virus type 1 (HIV-1) isolates in two groups of HIV-1-infected long-term nonprogressors.
    Zhang YJ; Fracasso C; Fiore JR; Björndal A; Angarano G; Gringeri A; Fenyö EM
    J Infect Dis; 1997 Nov; 176(5):1180-7. PubMed ID: 9359717
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Isolation of human immune deficiency virus from African AIDS patients and from persons without AIDS or IgG antibody to human immune deficiency virus.
    McCormick JB; Krebs JW; Mitchell SW; Feorino PM; Getchell JP; Odio W; Kapita B; Quinn TC; Piot P
    Am J Trop Med Hyg; 1987 Jan; 36(1):102-6. PubMed ID: 2949638
    [TBL] [Abstract][Full Text] [Related]  

  • 57. AIDS studies in Japan.
    Harada S; Yamamoto N
    Jpn J Cancer Res; 1987 May; 78(5):415-27. PubMed ID: 3112053
    [TBL] [Abstract][Full Text] [Related]  

  • 58. T-cell colony formation in homosexual men with anti-human immunodeficiency virus.
    Wakabayashi Y; Ishiyama T; Sugimoto M; Abe S; Horie S; Matsumoto T; Hirose S
    Nihon Ketsueki Gakkai Zasshi; 1989 Feb; 52(1):80-5. PubMed ID: 2787090
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neutralizing antibody and clinical status of human immunodeficiency virus (HIV)-infected individuals.
    Alesi DR; Ajello F; Lupo G; Vitale F; Portera M; Spadaro F; Romano N
    J Med Virol; 1989 Jan; 27(1):7-12. PubMed ID: 2784162
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The immunosuppressive peptide of HIV-1: functional domains and immune response in AIDS patients.
    Denner J; Norley S; Kurth R
    AIDS; 1994 Aug; 8(8):1063-72. PubMed ID: 7986401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.